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The bacterial effector proteins SseK and NleB glycosylate host proteins on arginine residues,
leading to reduced NF-κB-dependent responses to infection. Salmonella SseK1 and SseK2 are
E. coli NleB1 orthologs that behave as NleB1-like GTs, although they differ in protein substrate
speciﬁcity. Here we report that these enzymes are retaining glycosyltransferases composed
of a helix-loop-helix (HLH) domain, a lid domain, and a catalytic domain. A conserved HEN
motif (His-Glu-Asn) in the active site is important for enzyme catalysis and bacterial viru-
lence. We observe differences between SseK1 and SseK2 in interactions with substrates and
identify substrate residues that are critical for enzyme recognition. Long Molecular Dynamics
simulations suggest that the HLH domain determines substrate speciﬁcity and the lid-domain
regulates the opening of the active site. Overall, our data suggest a front-face SNi mechanism,
explain differences in activities among these effectors, and have implications for future drug
development against enteric pathogens.
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Protein glycosylation is a post-translational modiﬁcationimplicated in a wide range of cellular/biological processes,including cell development, signaling cascades, and
tumorigenesis1. Glycosyltransferases (GTs) catalyze the transfer
of a sugar moiety to acceptor substrates and are classiﬁed
according to their folding as GT-A, GT-B, GT-C2 or GT-D3.
Most GT-A fold GTs are single domain proteins that contain a
Rossmann-like fold though exceptions to this rule exist4. GT-A
GTs also have a DxD (Asp-x-Asp) motif, which is required to
coordinate the divalent cation (cofactor). The donor substrates
include sugar-linked nucleotide diphosphates that also interact
with the cofactor. Within proteins as acceptor substrates for GTs,
the most prevalent glycosylated amino acids are serine and
threonine (O-linked glycosylation), and asparagine (N-linked
glycosylation).
Another type of glycosylation was recently reported from
studies of bacterial virulence proteins5–7. Enteropathogenic
Escherichia coli (EPEC) and enterohemorrhagic Escherichia coli
(EHEC) express numerous effector proteins8 which are injected
into host cells via a type III secretion system (T3SS) to disrupt
host cell functions9. The NF-κB transcription factor plays a
central role in inducing immune responses against microbial
pathogens. Some bacterial effectors suppress NF-κB itself or NF-
κB-associated factors10–14. The T3SS and many effectors are
encoded in the locus of enterocyte effacement (LEE)15. Effectors
encoded outside this region are designed as non-LEE effectors
(Nles)16. The non-LEE encoded effector protein B (NleB) has GT
activity and inhibits NF-κB activation by transferring N-acetyl
glucosamine (GlcNAc) to host death domain-containing proteins
and to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)5–7.
The glycosylation target is an arginine residue, which was unex-
pected because the guanidine group of arginine is nucleophilically
poor at physiological pH.
NleB target proteins include the tumor necrosis factor receptor
type 1-associated death domain (TRADD), Fas-associated death
domain (FADD), receptor-interacting serine/threonine-protein
kinase 1 death domain (RIP1-DD), tumor necrosis factor receptor
death domain (TNFR-DD), and GAPDH5–7. Most of these pro-
teins participate in regulating the tumor necrosis factor-alpha
(TNF-α) mediated apoptosis pathway via death domain mediated
homo- or hetero-oligomerization10. Previous studies have
reported that glycosylation of FADD Arg117 and TRADD
Arg235 disrupts apoptosis and decreases NF-κB signaling in host
cells5,6. Glycosylation of GAPDH Arg197 and Arg200 inhibits
ubiquitination of the TNF receptor-associated factors (TRAF) 2
and 3, leading to reduced NF-κB signaling and type I interferon
production17,18.
The T3SS effectors SseK1 and SseK2 from Salmonella typhi-
murium SL1344 are NleB orthologs that behave as NleB1-like
GTs, although they differ in protein substrate speciﬁcity6,18. The
third member, SseK3, is inactive against FADD and GAPDH but
active against TRADD18,19. Recently, the structure of SseK3 was
determined, revealing a GT-A fold19. However, the speciﬁc
enzyme mechanism and the identiﬁcation of the catalytic base
remain unclear. There are also discrepancies regarding whether
these enzymes are retaining or inverting GTs because this has not
been experimentally probed19,20. In addition, details regarding
substrate speciﬁcity based on structural evidence are also limited
due to the lack of ternary complexes. Here, by using a combi-
nation of X-ray crystallography, STD-NMR, enzyme kinetics,
molecular dynamics simulations, and in vivo experiments, we
show that these enzymes are GT-A fold retaining GTs that most
likely follow an SNi mechanism. We demonstrate that the HLH
domain is relevant to protein substrate recognition and the HEN
residues are critical for catalysis. We also determine differences
within the SseK/NleB family on recognition of the sugar
nucleotide and peptide substrates and ﬁnd common features for
the three peptides such as the recognition of the conserved Trp
and Arg residues (WR-motif). Finally, molecular dynamics
simulations reveal that the presence of GlcNAc in the donor site
induces conformational changes on the side chains of the peptide
substrate so that the ﬁnal arginine acceptor becomes properly
oriented for a front face attack to the anomeric C1 carbon of the
sugar.
Results
Anomeric conﬁguration of glycosylated peptides. Recently it
was proposed, though not experimentally demonstrated, that
SseK3 is a retaining GT19. However, and in contrast to this,
another NleB study synthesized Arg-N-GlcNAc-containing gly-
copeptides in a β-conﬁguration, implying that these enzymes are
inverting GTs20. To resolve these discrepancies, we investigated
by NMR spectroscopy the glycosidic bond conﬁguration of a
GlcNAc-GAPDH187-203 glycopeptide, which was formed enzy-
matically by incubation with SseK1 and UDP-GlcNAc/MnCl2.
From 2D 1H,13C-CLIP-HSQC we measured the 1JCH coupling at
the anomeric position of the transferred GlcNAc to be 168 Hz,
characteristic of an α-linkage (Fig. 1). These data suggest that the
transfer of GlcNAc by SseK1 follows a retaining mechanism.
Considering the conserved active site residues and the structural
similarity between SseK1 and SseK2/SseK3, SseK2/SseK3 also
might be retaining GTs (detailed information is described below).
Overall enzyme architecture. We solved the crystal structures of
Salmonella enterica serovar Typhimurium SL1344 SseK1 in
complex with UDP. SseK2 was solved both in its unliganded form
and in complex with UDP and UDP-GlcNAc. NleB2 from E. coli
O145:H28 was solved in its unliganded form. (Supplementary
Table 1). For overexpression and crystallization, amino acids
1–20 and 1–33 at the N-terminus of SseK1 and SseK2 were
truncated, respectively. This N-terminal region is predicted to be
unstructured and presumably play a role in secretion and trans-
location into the host cell21. Proteins containing these N-termini
failed to crystallize. Point mutations (C39S, C210S) were intro-
duced into SseK1 to prevent protein precipitation due to irregular
intermolecular disulﬁde binding. For NleB2, amino acids 317–326
at the C-terminus were deleted for better crystal packing and
Cys21 and Cys199 were also substituted to serine (Fig. 2a).
Unambiguous electron density maps for uridine 5′-diphospho-N-
acetylglucosamine (UDP-GlcNAc) or uridine 5′-diphosphate
(UDP) were visualized in the active sites of the crystal structures
(Fig. 2b).
The sequence identity among SseK1, SseK2, and NleB1 ranges
from ~ 60-65%. The N-termini, whose function is presumably to
facilitate protein translocation into host cells, differ the most
among orthologs, while the rest of the sequence is highly
conserved22. Hereafter, we will focus primarily on the biochem-
istry for SseK1 because SseK1 is more active than SseK2. For
structural analyses, we focus on SseK2 because the data-sets for
this protein were obtained at a higher resolution, with three
different snapshots of the active site. SseK2 possesses an overall
protein fold composed of 15 α-helices and 9 β-strands that is
highly similar to SseK1 and NleB2 (RMSD= 1.8 Å/1.8 Å, Z-score
= 37.2/37.4, number of compared residues= 304/304 to SseK1/
NleB2, respectively based on DALI pairwise comparison23)
(Fig. 2c, d). These structures belong to the GT-A class, which
has two abutting β/α/β Rossmann-like domains4 (β3-α2-β4-α3-
β5) and contains an Asp-x-Asp (DxD) motif in the active site
(SseK2D239-x-D241, SseK1D223-x-D225, and NleB2D218-x-D220).
SseK2 can be divided into three types of sub-domains, namely
the catalytic domain (40–147 and 185–336), which includes the
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Rossmann-like domains, the protruded helix-loop-helix (HLH)
domain (148–184), and the C-terminal lid domain (337–348)
(Fig. 2e). The concave shape of the catalytic domain is composed
of an α-helix and β-strand mixture, and similar to other GT-A
structures, continuous central β-strands (β8, β9, β6, β3, β4, β5)
form a mixture of parallel and anti-parallel strands. The C-
terminal lid domain is highly ﬂexible in the absence of a ligand.
Therefore, the electron density map for this domain was not
resolved. However, in the structures with UDP and UDP-
GlcNAc, the substrate leads to an unambiguous electron density
map for the C-terminal lid domain, implying that the domain is
well ordered only in the presence of the nucleotide (detailed
information is described below).
Recently, the crystal structure of EarP, an arginine rhamnosyl-
transferase, was solved, revealing a GT-B fold and an inverting
catalytic mechanism in which a glutamate residue acts as the
catalytic base24–26. Hence, SseK and EarP are likely to differ in
their catalytic mechanisms (see below).
Donor substrate binding mode. Based on the complexes of
SseK2 with UDP and UDP-GlcNAc, we identiﬁed the donor-
substrate binding mode and substrate-mediated conformational
changes. UDP-GlcNAc consists of three groups, namely the uri-
dine, pyrophosphate, and GlcNAc, which will be discussed
independently. The uridine group has an aromatic ring tethered
by Phe203 and Trp65 through π-π stacking, water-mediated
indirect hydrogen bonds (backbones of Arg68 and Ser346), and
hydrogen bonding with the Phe66 backbone (Fig. 3a, upper
panel). This sandwich-like π-π stacking is an unusual interaction
in GTs because in most of them the sugar nucleotide uracil
moiety is sandwiched between an aromatic and an apolar non-
aromatic residue participating in π-π stacking and CH-π
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Fig. 1 SseK1 is a retaining-glycosyltransferase. NMR spectra showing the reaction product of GAPDH195-203 with SseK1. a Decoupled 1H-13C HSQC spectrum
(800MHz) showing the anomeric region, highlighting the presence of α-D-GlcNAc-GAPDH187-203, with a large 13C upﬁeld shift relative to the free species.
b Expansion of 1H-13C CLIP HSQC spectrum (500MHz) with no decoupling to measure the anomeric 1JCH coupling in α-GlcNAc-GAPDH187-203. A value
of 169Hz indicates an α-conﬁguration. c 1H-1H TOCSY spectrum highlighting through-bond correlation between the anomeric proton of α-D-GlcNAc
in GAPDH187-203-α-GlcNAc and an arginine η-proton
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interactions, respectively27,28 (Supplementary Fig. 1a), implying
that this unusual interaction is not a requirement for GTs that
prefer uracil-containing sugar nucleotides. However, this
sandwich-like π-π stacking interaction is unique for this family of
enzymes and is determinant for recognition of the uracil moiety
(see below).
Both SseK1 and SseK2 share sandwich-like aromatic π-π
stacking interactions and both the tryptophan and phenylalanine
residues are conserved in NleB2. However, in the sandwich-like
π-π stacking, the interaction modes of SseK1 and SseK2 are
slightly different. In contrast to SseK2, Trp331 from the C-
terminal lid of SseK1 interacts with the uracil base instead of
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Fig. 2 Overall enzyme architecture. a Colored ovals show the full-length amino acid sequence and the black line under the oval shows the amino acid
sequence used for overexpression and crystallization. b Arrange crystal structure and electron density maps of each ligands (2Fo – Fc electron density
maps of UDP on SseK1 and UDP & L-arginine on SseK2 contoured at 1σ and UDP and the others are 2σ). c Numbering of the α-helices and β-strands of
SseK2 and d superimposition of SseK1, SseK2, and NleB2. e Each sub-domain is presented in different colors (blue: HLH domain, yellow: catalytic domain,
red: lid domain)
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Fig. 3 UDP-GlcNAc binding mode in SseK2. a Uracil moiety of UDP-GlcNAc interacts with SseK2 through hydrogen bonds and π-π stacking (top panel), but
SseK1 uses a slightly different mechanism (second and third panel). Uracil binding mode of SseK3 is similar to SseK2 instead of SseK1 (bottom panel).
b GlcNAc moiety of UDP-GlcNAc interacts with Asp204, Arg207, Asp239, and Arg348 by hydrogen bonds. The carbonyl group of the acetyl of GlcNAc
interacts with a water molecule to stabilize the divalent metal ion. c Manganese ion coordinates six oxygens from pyrophosphate, Ser340, Asn338,
Asp241, and water. The DxD motif stabilizes both UDP-GlcNAc and manganese ion. *Amino acid numbering in brackets refers to conserved sequence of
SseK1. Black dashed lines represent hydrogen bonds
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Phe203 (Fig. 3a, second and third panels). To conﬁrm this
structural difference, we mutated the Phe residue of SseK1 and
SseK2 and measured the Kd for UDP-GlcNAc by using
isothermal titration calorimetry (ITC) (Supplementary Fig. 1b,
c). While the Kd measured for binding of UDP-GlcNAc to SseK1
F187A was similar to wild type SseK1, the Kd for binding of UDP-
GlcNAc to SseK2 F203A was increased about 13-fold as
compared to wild type SseK2. These data suggest that although
the sandwich-like π-π stacking interactions are maintained, the
uracil binding modes within SseK1 and SseK2 are slightly
different. In the SseK3 structure, SseK2-like π-π stacking
interaction is conserved and Phe190SseK3 and Trp52SseK3
(corresponding to Phe203SseK2 and Trp65SseK2) participate in
an interaction with the uridine group in the same orientation19
(Fig. 3a, bottom panel). Mutating Trp51SseK1 and Trp65SseK2 to
alanine abrogated UDP-GlcNAc binding to SseK1 and SseK2
(Supplementary Fig. 1b, c). The activity of the W51A mutant was
reduced more than the W331A mutant, as measured in NF-κB
activation assays, which was consistent with ITC assay data
(Supplementary Fig. 1d). Overall, Trp51SseK1 and Trp65SseK2
appear to be more critical than Trp331SseK1 and Phe203SseK2 for
π-π stacking interactions with UDP-GlcNAc, Note that for all
sugar nucleotides the binding energy is dominated by a large
negative enthalpic term and to a lesser extent by a non-favored
entropic term (Supplementary Fig. 1b, c).
The GlcNAc moiety of UDP-GlcNAc establishes hydrogen
bond interactions with Asp204, Arg207, Asp239, and Arg348.
The acetyl group of GlcNAc stabilizes the manganese ion by
water-mediated hydrogen bonds (Fig. 3b). The importance of the
acetyl moiety was conﬁrmed by ITC data that show increased Kd
of UDP-glucose (UDP-Glc) and UDP-galactose (UDP-Gal) as
compared to the Kd of UDP-GlcNAc for SseK1 (Supplementary
Fig. 1b, c). In comparison to UDP-GlcNAc, UDP-Glc lacks the
acetyl group, leading to a decrease in the enzyme-substrate
binding afﬁnity of about 16.5-fold. Moreover, in UDP-Gal, the
absence of the acetyl group and the presence of an inverted C4
hydroxyl group may lead to steric hindrance with the enzyme,
leading to the weakest Kd (69.1-fold weaker than the Kd of UDP-
GlcNAc). The binding afﬁnities of SseK1 and SseK3 for UDP-Glc
and UDP-Gal are relatively different19; however, their binding
afﬁnities for UDP-GlcNAc are similar (2.3, 1.2, and 1.9 µM for
SseK1, SseK2, and SseK3, respectively)19. Overall, the SseK
enzymes possess an architecture that is optimized for binding
UDP-GlcNAc.
Most GT-A GTs have a DxD motif that is required for
enzymatic activity29. The DxD motif in SseK2 has two signiﬁcant
functions, the coordination of manganese ion and the interaction
with the GlcNAc group (Fig. 3c). The manganese ion acts as a
bridge between SseK2 and the pyrophosphate of UDP-GlcNAc.
In the absence of manganese, the DxD motif-mediated donor-
substrate binding would not be expected to occur due to the
negative charge repulsion between DxD and the pyrophosphate
of UDP-GlcNAc. An octahedral molecular geometry was
visualized for the manganese ion coordinated to six oxygens
from the UDP pyrophosphate, Asp241, Ser340, Asn338, and a
water molecule. Asp239 interacts with a water molecule and a
GlcNAc moiety via hydrogen bonds. Asp241 interacts with both a
manganese ion and with a water molecule that stabilizes the
manganese ion. Most of the residues that interact with UDP-
GlcNAc are highly conserved in the SseK and NleB families
(Supplementary Fig. 2).
Conformational change by the donor-substrate binding. After
donor-substrate binding, several GTs undergo large local con-
formational changes. For example, human glycogenin1 (hGYG1)
has a lid, an acceptor arm, and a C-terminal loop. Their con-
formational rearrangement inﬂuences the accessibility of the
substrate at the active site and in turn their catalytic activity30.
The SseK2 structure undergoes a dramatic conformational change
induced by donor-substrate binding. In the ground state of SseK2,
the C-terminal lid domain is highly ﬂexible, impeding its visua-
lization in the crystal structure. In this state, the donor-substrate
binding site might be fully exposed to allow the access of UDP-
GlcNAc (Fig. 4a, left panel). After UDP-GlcNAc binds to the
active site, the α10 helix is tilted towards the UDP-GlcNAc by ~
3.5° and the C-terminal lid domain covers up the active site to
stabilize the bound substrate and to restrict the accessibility of
water molecules (Fig. 4a, right panel and Fig. 4b). The closure of
the C-terminal lid in the presence of UDP-GlcNAc determines a
closed conformation for this family of enzymes. We truncated the
lid domain (SseK1 1-321) and found that the Kd of UDP-GlcNAc
binding increased about 155.3-fold for the lid domain truncation,
as compared to the wild type protein (Supplementary Fig. 1b, c),
suggesting that the C-terminal lid domain plays a key role for
donor-substrate binding.
Both Trp334 and Arg335 in the C-terminal lid domain of
SseK3 (corresponding to Trp347SseK2 and Arg348SseK2) interact
with UDP-GlcNAc19. This interaction is highly similar to that of
SseK2. It was reported that Trp334 and Arg335 in SseK3 are
essential for enzyme activity19. The amino acid sequence of the C-
terminal lid domain of SseK1 is slightly different from SseK2 and
SseK3. The conserved arginine residue in SseK2 and SseK3
(Arg348SseK2, Arg335SseK3), which is located in the lid domain, is
substituted to an alanine residue in SseK1 (Ala332SseK1). In
addition, an arginine residue is located next to an alanine residue
(Arg333SseK1). In the crystal structure of UDP-bound SseK1, the
backbone direction of Ala332 is located at the opposite side of
UDP (Fig. 4c). This implies that the lid domain of SseK1 is likely
more ﬂexible than SseK2 and SseK3. Furthermore, the sequence
alignment shows that the NleB family lacks the arginine residue,
though a conserved Trp is present at the C-terminus. We would
expect that both the SseK and NleB families have a different
conformational behavior of the lid-domain.
Peptide substrate recognition by SseK1 and SseK2. To obtain
structural information on the molecular recognition of the sub-
strates, we performed saturation transfer difference (STD) NMR
experiments using short peptides from FADD, TRADD, and
GAPDH. Standard homo- and heteronuclear 2D NMR techni-
ques were used to obtain the chemical shift assignments of
GAPDH195-203, FADD110-118, and TRADD229-237 (Supplementary
Table 5–7). For each peptide, four different enzyme systems were
prepared: apo-SseK1, apo-SseK2, holo-SseK1, and holo-SseK2,
where apo and holo stand for the enzyme without and with Mn2+
and UDP, respectively. We observed that all three peptides bound
to both SseK1 and SseK2, irrespectively of the forms used in the
experiments (Supplementary Fig. 3, 4). These data imply that
binding of the short peptide ligands occurs independently of
enzymatic activity and can also take place in the absence of the
sugar nucleotide. In STD NMR experiments, strong signal
intensities from different hydrogen atoms of the ligand permit
identiﬁcation of the main contacts of the peptides with the
enzyme in the bound state31,32. After intensity normalization,
binding epitope maps of the peptides were obtained (Fig. 5 and
Supplementary Fig. 5). In all cases, high STD signals, indicating
close contacts, were observed for the conserved Trp and Arg side
chains. The results support the concept that a WR-motif (W112/
R113 in FADD, W230/R231 in TRADD, and W196/R197 in
GAPDH) appears to be central for recognition. For TRADD229-
237, although rather similar binding modes to SseK1 and SseK2
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were observed, the binding epitope was spread across the entire
molecule when bound to SseK1 but was more concentrated
around the WR-motif for SseK2. The epitopes of FADD110-118 are
comparable when bound to either SseK1 or SseK2. For
GAPDH195-203, differences in binding to both enzymes were
observed. For the binding of GAPDH195-203 to SseK1, the data
support a signiﬁcant conformational rearrangement of the pep-
tide ligand upon addition of Mn2+ and UDP. This was evidenced
by a signiﬁcant change in the binding epitope mapping, parti-
cularly a large increase in STD intensities for the arginine side-
b
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chains (Fig. 5c, d). However, for all other peptides, and for
GAPDH195-203 binding to SseK2, no such rearrangement occurs
(Supplementary Fig. 6).
To elucidate the speciﬁc role of the WR-motif, we measured
the kinetics of SseK1 to four GAPDH187-203-derived synthetic
peptides (designated as WT, W196A, R197A, and W196A/
R197A). Each of the W196A, R197A, and W196A/R197A mutant
forms decreased the catalytic efﬁciency of about 40.5%, 47.4%,
and 17.3%, respectively as compared to WT GAPDH187-203
peptide (Supplementary Fig. 16b). In particular, the double
mutant form (W196A/R197A) synergistically decreased enzyme
catalysis, supporting our STD-NMR experiments that suggested
that the WR-motif of the peptides is of utmost importance for
binding to these enzymes.
To investigate the relevance of the WR-motif for binding, we
also carried out STD NMR experiments focused on analyzing the
impact of single and double mutations on the afﬁnity of the
molecular recognition of the synthetic peptide TRADD229-237. As
we were interested only in analyzing the impact on binding, we
ran competition experiments for the interactions of the
TRADD229-237-derived peptides with SseK1. Five synthetic
peptides (designated as WT, W230A, R231A, W230A/R231A,
and R235A) were analyzed. All of them bound to SseK1, as
detected by STD NMR, yet their afﬁnities were different, as
reﬂected in their differences in average STD NMR intensities (e.g.,
the most intense alpha proton showed 14%, 9%, 6%, 4%, and 10%
for WT, W230A, R231A, W230A/R231A, R235A, respectively).
This result indicates that the highest afﬁnity for SseK1 is achieved
when the full WR-motif is present. Again, the results were
compatible with the double mutant showing the lowest binding
afﬁnity. We then conﬁrmed the differences in afﬁnity compared
to the WT peptide by performing competition STD NMR
experiments. In binary samples containing SseK1 and equimolar
concentrations of the TRADD229-237 and one of the mutant
TRADD peptides, none of the mutants was able to signiﬁcantly
displace the WT peptide, which demonstrates that modiﬁcations
at the WR-motif impact negatively the afﬁnity of the peptide for
the enzyme (Supplementary Figs. 19, 20)
STD NMR data revealed that all the peptide ligands were
recognized in solution. Hence, it is clear that differences in
glycosylation of full-length FADD, TRADD, and GAPDH
substrates by SseK1 and SseK2 are not due to differences in
binding modes of their death domain sequences, but instead due
to differences outside the binding site. In agreement with the
similarity of binding modes of the short peptides detected by STD
NMR, most of the sequence differences of SseK1 and SseK2 are
likely in regions away from the binding site, including the HLH
domain. Hence, differences in glycosylation speciﬁcity may be
attributed to differences in the internal dynamics between the two
enzymes at those distinct regions.
To test that hypothesis, we ran long (800 ns) Gaussian
accelerated molecular dynamics (GaMD) simulations of SseK1
and SseK233. Principal component analysis (PCA) showed that,
in both cases, the motions of largest amplitude are indeed present
around the HLH domain (Supplementary Fig. 7e, f), primarily
due to rotation of the HLH towards the binding site
(Supplementary Fig. 7a, b). Noticeably, the simulations showed
that SseK1 is signiﬁcantly more ﬂexible than SseK2 in the loop
region connecting the HLH (Supplementary Fig. 7e, f). Addi-
tionally, signiﬁcant differences were observed at the tip of the
HLH, as SseK2 exhibited a substantial tilting motion towards the
binding site (Supplementary Fig. 7c, d). These data reveal that
there exist signiﬁcant differences in the dynamics of the HLH
domain between SseK1 and SseK2 that affect the HLH domain
approach towards the substrate binding pocket, which could
explain the differences in substrate speciﬁcity of these two
enzymes and in turn, glycosylation.
To understand further the molecular basis of substrate peptide
recognition we generated a ternary SseK2:UDP-GlcNAc:
FADD110-118 complex using an induced ﬁt molecular docking
protocol. Since this ternary complex was not accessible
experimentally neither by X-ray crystallography nor by NMR
spectroscopy, molecular modeling provides the only insight into
the structure of the full complex in the presence of both the donor
sugar nucleotide and the acceptor. Peptide structure prediction
and NMR chemical shift indexing indicated that the peptide
remained in its native helical conformation (Supplementary
Fig. 8). Docking of FADD110-118 was only possible using the
SseK2 structure with the C-terminal lid in the open conforma-
tion, since the closed lid precludes access to the binding site. The
resulting model was in good agreement with STD NMR data,
with Trp112FADD and Arg113FADD in close proximity to the
protein surface (Supplementary Fig. 9a, b). In addition, the
sidechain of Arg113FADD was also found in close proximity to
His260, Glu271, and Asn338, as observed in the docking of the
acceptor Arg to the SseK2-UDP-GlcNAc crystal structure
(Supplementary Fig. 9c and see below).
Furthermore, it was possible to graft the published 3D
structure of the full-length FADD protein (PDB 3EZQ) into
our SseK2:UDP-GlcNAc:FADD110-118 model complex without
any signiﬁcant atomic overlap (Supplementary Fig. 10). We
wanted to investigate whether the presence of the GlcNAc ring in
the donor substrate might have an impact on the acceptor
binding mode, and to analyze the dynamics of the full ternary
SseK2:UDP-GlcNAc:FADD. We subjected this complex to a 500
ns Gaussian GaMD simulation. PCA showed that the most
signiﬁcant motions involved rotation and translation (Supple-
mentary Fig. 11a, b) of both the SseK2 HLH and the FADD C-
terminal α-helix towards one another. A distinct energy
minimum was observed at short inter-helical distances (Supple-
mentary Fig. 11c). At this minimum, a clear intermolecular
complementarity was observed. In particular, electrostatic inter-
actions were observed between Lys176SseK2 and Asp175FADD,
and between Asp180SseK2 and Arg166FADD (Supplementary
Fig. 12a). Leu172FADD interacts with a hydrophobic patch
deﬁned by Val169SseK2 and Leu170SseK2. The α3-helix of FADD
is highly negatively charged and interacts closely with Lys264,
Arg348, and the manganese ion of SseK2 (Supplementary
Fig. 12b). Our simulation suggests that Asp123 of FADD directly
coordinates the manganese ion. Finally, along the 500 ns of the
Fig. 4 Donor substrate-mediated conformational changes. a Comparison of surface structures between apo form and UDP-GlcNAc bound SseK2. The
ﬂexible C-terminus creates an open conformation for access of UDP-GlcNAc and after binding of the UDP-GlcNAc, the C-terminal lid domain (red color)
interacts with UDP-GlcNAc and is ﬁxed in closed conformation. Yellow stick represents UDP-GlcNAc. b After the donor-substrate binds to the active site,
the α10 helix tilts about 3.5 degrees and the ﬂexible C-terminal lid domain is ﬁxed towards the UDP-GlcNAc. Due to hydrogen bonding at Arg207, Asp204,
and aromatic stacking at Phe203, the α10 helix is able to tilt. The ﬂexible C-terminal lid domain can be ﬁxed by hydrogen bonding of Ser340, Ser345,
Ser346, Arg348, and Trp347. Orange and blue-green colors represent SseK2 apo and UDP-GlcNAc bound SseK2 structure, respectively. Black dashed lines
represent hydrogen bonds. c Direction of the lid-domain is different between the SseK1 (in green) and SseK2 (in white) structures. Curved arrows (in
black) each correspond to the direction of the backbone of the lid-domain
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Fig. 5 Binding modes of short peptide substrates. Binding epitope mappings of a FADD110-118 b TRADD229-237 and c, d GAPDH195-203 peptides in the
presence of 25 μM SseK1. Samples in a, b and d contained 25 μM Mn2+, and 25 μM UDP. All STD intensities normalized against Hζ2 of the tryptophan.
Colored circles represent magnitude of normalized intensities (blue:< 40%, pink: 40–70%, red:> 70%). Comparison of GAPDH195–203 binding to SseK1, c in
the absence, and, d in the presence of Mn2+ and UDP, reveals a signiﬁcant change in the binding mode of the substrate peptide upon addition of the
cofactor and the nucleotide diphosphate. For STD NMR study of binding to SseK2 see Supplementary Fig. 5
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GaMD simulations, signiﬁcant conformational rearrangements of
the arginine side chains in the FADD110-118 region were observed
(Supplementary Fig. 13a–d). On average, Arg117 of FADD is the
residue from FADD showing the shortest distance to the C1
anomeric carbon of UDP-GlcNAc, and is the only one
simultaneously establishing close contacts with His260, Glu271,
and the beta-phosphate of UDP-GlcNAc.
Together, these data provide evidence for speciﬁc recognition
of FADD by SseK2 via interactions far from the active site, which
may provide insight into differences in substrate glycosylation
speciﬁcity of SseK1 and SseK2. These data also suggest that
Arg117 is the best oriented residue from FADD for accepting the
transferred glycosyl from the donor UDP-GlcNAc, in keeping
with the role of this residue as the only acceptor site in FADD5,6.
Catalytic importance of HEN motif. In the SseK2-UDP-GlcNAc
crystal structure (chain D), Asn272 (corresponding to Asn256S-
seK1) is closer to the C1 anomeric carbon of UDP-GlcNAc (5.1 Å)
as compared to Glu271 (5.6 Å). These data indicate that the
Asn272 may play an important role in binding and catalysis. In
addition, Glu271 is located at the entrance of the putative
acceptor arginine-binding site. To obtain insight into the
importance of these residues in substrate recognition, we con-
ducted in-silico docking of the acceptor Arg to the SseK2-UDP
crystal structure. It was observed that a closed conformation of
SseK2 structure possesses a putative acceptor substrate binding
site pocket that is connected to the anomeric carbon of GlcNAc.
We used a closed conformation of SseK2 with a putative acceptor
substrate binding site pocket connected to the anomeric carbon of
GlcNAc for automated computational docking (Discovery Studio,
Accelrys). As a result, the negatively charged pocket of the con-
cave active site interacts with the positively charged guanidine
group. In particular, Glu271, the β-phosphate of UDP, and
His260 were located in a position suitable for hydrogen bonding
(Supplementary Fig. 14a). All of these residues are highly con-
served in the SseK and NleB families (Supplementary Fig. 2).
In the docking structure of SseK2, a single negatively charged
residue (Glu271SseK2) and an additional β-phosphate from UDP
are in close contact to the guanidinium group of the acceptor Arg.
The Glu271SseK2 corresponds to the Glu253NleB1 whose mutation
to Ala did not inhibit NF-κB signaling6, in agreement with the
importance of this residue in glycosylation of the acceptor Arg.
Further studies are required to determine its precise role either in
catalysis or binding (see below).
In addition, His260SseK2 is located near the guanidinium group
of the acceptor Arg. A pH activity proﬁle for both SseK1 and
NleB1 revealed that NleB1 and SseK1 have an optimal pH
between 6.0 ~ 8.0 and 6.0 ~ 8.5, respectively (Supplementary
Fig. 14b). This highlights the potential role of histidine as a
catalytic base because the pKa value of histidine is ~ 6.0. To test
the role of these residues in substrate recognition and catalysis, we
mutated His260, Glu271, and Asn272, which together form the
‘HEN’ motif. This motif is highly conserved at both the primary
sequence and tertiary structure levels (Supplementary Fig. 15).
Wild-type (WT) SseK1 and the HEN motif single mutants were
overexpressed with TRADD in HEK293T cells. WT SseK1
inhibited cPARP production (Fig. 6a). As expected, the DxD-
AxA double mutant, resulted in an increase in cPARP level. The
HEN motif single mutants (His260, Glu271, and Asn272 in
SseK2) led to an increase in the cPARP levels, a similar outcome
to the DxD-AxA double mutant. When we observed the
oligomerization form in a non-reducing gel, TRADD oligomer
was detected in the mutant forms, suggesting that each mutant
loses its glycosylation activity and fails to inhibit TRADD
oligomerization.
NF-κB activity data in A549 cells correlated highly with the
results from the PARP cleavage assay (Fig. 6b). Surprisingly, NF-
κB levels increased more in H244A, E255A, and N256A than in
the AxA mutant. Furthermore, we also investigated enzyme
kinetics using the L-arginine substrate and the puriﬁed
recombinant SseK1 and SseK2 (Fig. 6c, Supplementary Fig. 16a).
The catalytic activities of the mutants (H244A/H260A, E255A/
E271A, and N256A/N272A in SseK1/SseK2) decreased signiﬁ-
cantly compared to WT, though they were not essential for
activity. The H244A/H260A and N256A/N272A mutants showed
lower catalytic activity than the DxD-AxA double mutant.
We also studied the glycosylation activity of WT and HEN
mutant enzymes in vitro, in cell culture, and in mouse infection
experiments using C. rodentium. We ﬁrst incubated NleB1,
NleB2, SseK1, or SseK2 with FADD, TRADD, or GAPDH. We
observed that, consistent with previous studies7,18, WT NleB1,
SseK1, and SseK2 glycosylated FADD (Fig. 6d). None of the point
mutations in the HEN motif of any of the enzymes retained the
ability to glycosylate FADD (Fig. 6d). Similar data were observed
in studies of TRADD and GAPDH glycosylation (Fig. 6e, f). We
also noticed that NleB1 and SseK1 are self-glycosylated, though
the functional importance of this modiﬁcation is unknown.
We also measured the ability of NleB1 and SseK1 to glycosylate
TRADD and GAPDH when co-transfected into HEK 293T cells.
We immunoprecipitated TRADD or GAPDH using an anti-
FLAG antibody and then performed Western blotting for Arg-
GlcNAc. Similar to our in vitro studies, we failed to observe any
glycosylation of host substrates by any HEN mutation (Fig. 6g, h).
To extend these data, we conducted a series of mouse challenge
experiments with Citrobacter rodentium. C. rodentium has only 1
copy of NleB, which functions similarly to EHEC NleB118. To
evaluate whether the HEN motif of NleB is important to C.
rodentium virulence, we deleted the C. rodentium nleB gene and
then complemented this mutant with different EHEC nleB1 and
nleB2 expression plasmids. We infected mice with C. rodentium
ΔnleB strains expressing either WT NleB1 (ΔnleB/pnleB1) or the
HEN mutants H242A, E253A, and N254A. Mice infected with
ΔnleB C. rodentium showed an approximately 100-fold reduction
in colonization magnitude after 14 days, as compared with WT C.
rodentium, in support of previous ﬁndings7 (Fig. 6i). While this
mutant was fully complemented by expressing WT EHEC NleB1,
none of the HEN mutants complemented the colonization defect
(Fig. 6i). Additionally, neither WT EHEC NleB2 nor an NleB2
mutant in which all HEN amino acids were mutated to alanines
complemented the colonization defect. These data demonstrate
that the HEN motif is highly important for enzymatic activity and
virulence.
Proposed mechanism. Three reaction mechanisms have been
proposed for retaining GTs, namely SN2, SNi, and orthogonal
mechanisms. While the SN2 mechanism involves a double-
displacement reaction requiring a nucleophilic residue to form a
covalent glycosyl intermediate34, both the SNi and the orthogonal
mechanisms involve a single displacement reaction in which the
β-phosphate of the nucleotide acts as the catalytic base35–37.
However, the SNi and the orthogonal mechanisms differ in their
reaction proﬁles and the timing of bond formation and bond
breakage37. These differences lead to a dissociative and associative
transition state for the SNi and the orthogonal mechanism,
respectively37. Unlike the SNi mechanism that has been probed
extensively, the SN2 and the orthogonal mechanism have never
been demonstrated experimentally34–37. In our crystal structure,
Asn256SseK1 was located in a possible position for the back-side
attack of the C1 anomeric carbon of UDP-GlcNAc through an
SN2 reaction. However, our kinetic assay results showed that this
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residue is not essential for catalysis (its mutation to alanine in
both SseK1 and SseK2 reduced its Kcat by 80 % as compared to
the WT enzymes). This result is unexpected because other GTs
completely lose their catalytic activity (650-fold to 23,000-fold
decrease) when a potential nucleophile residue was mutated to a
non-nucleophile residue38,39. It was proposed that Glu258 of
SseK3 acts as the nucleophile residue for an SN2 reaction (cor-
responding to Glu255SseK1 and Glu271SseK2). However, the
E255ASseK1 and E271ASseK2 mutants still possess an activity of 70
and 24%, respectively, ruling out its potential role as a nucleo-
philic residue. Additionally, our GaMD simulations of the grafted
complex of SseK2 with FADD supported the relevance of Glu271
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and His260 in Arg recognition, as they established stable inter-
actions with the guanidinium group of Arg117 of FADD (Sup-
plementary Fig. 13b, c). In turn, the center of mass of the
guanidinium of Arg117FADD was 4 Å from the anomeric carbon
of the GlcNAc residue of the donor substrate in the 500 ns
simulations, in a location compatible with a front face mechanism
for glycosyl transfer with retention of anomeric conﬁguration (see
below; Supplementary Fig. 13e). Hence, our results are more
consistent with an SNi mechanism in which the β-phosphate of
the UDP formed in the reaction acts as the catalytic base to fully
activate the acceptor Arg, but are inconsistent with the SN2 based
double-displacement mechanism proposed earlier (Supplemen-
tary Fig. 17). Note that we cannot rule out the possibility of these
enzymes following an orthogonal mechanism, although as men-
tioned previously, this mechanism has never been probed
experimentally.
Discussion
The overall crystal structures of SseK1 and SseK2 from S. typhi-
murium as well as NleB2 from enteropathogenic E. coli are
similar, revealing high identities between the amino acids at the
active binding site level. These enzymes glycosylate the guanidi-
nium moiety of Arg residues, which are residues with poor
nucleophilic character because electrons on this moiety are par-
tially delocalized. In addition, we identiﬁed several characteristics
in the active site that are compatible with an SNi mechanism and
with the role of HEN motif residues in catalysis: (a) we experi-
mentally demonstrate by NMR that these enzymes are retaining
GTs; (b) donor-substrate-mediated ﬁxation of the C-terminal lid
could shield the active site from the hydrophilic environment,
avoiding unwanted hydrolysis of UDP-GlcNAc, -a behavior
reported in other retaining GT-A fold GTs such as Legionella
pneumophila glucosyltransferase27 and the toxin B;40 (c) muta-
tions of the HEN motif lead to a signiﬁcant reduction in glyco-
sylation both at in vitro and in vivo levels, implying that these
residues affect enzyme catalysis. Based upon our kinetic, struc-
tural, and computational studies, we suggest that His and Glu
might improve the poor nucleophile character of the acceptor Arg
guanidinium moiety to facilitate catalysis; and (d) based on our
MD simulations, the acceptor Arg is facing the anomeric carbon,
which is compatible with a front face mechanism for glycosyl
transfer with retention of anomeric conﬁguration.
Each HEN residue of SseK3 is on the β-strand, but in the case
of SseK1, SseK2, and NleB2, the HEN residues are located on the
loop structure. This has implications for the differences in the
activity of the enzymes due to the HEN motif because the loop
structure is more ﬂexible than the β-strand. In addition, there are
differences in the regulation of the C-terminal lid domain
between SseK1, SseK2, and SseK3. The arginine on the C-
terminus participates in an interaction with UDP-GlcNAc in
SseK2 and SseK3, but not in SseK1. Based on this result, the
departure of the leaving group is likely to be easier, due to a
weaker enzyme-substrate interaction network in SseK1, than in
SseK2 and SesK3. We suggest that this may also be a reason for
the differences in enzyme activity in the SseK family.
Although the tertiary structure of NleB1 is likely similar to
NleB2, SseK1, and SseK2, a previous study has reported that
NleB2 has a lower activity than NleB1 on the same target
(TRADD)6. In this study, we also demonstrate that the enzymatic
activity of SseK1 is ~ 62 times higher than that of SseK2 based on
enzyme kinetic assays. The substrate speciﬁcities of the NleB/SseK
family of C. rodentium, Escherichia coli and Salmonella enterica
are different18. Based on these differences, we can infer from the
crystal structures that these discrepancies between orthologs of
this family might be attributed partially to the HLH domain,
which is a structural feature not present in other GTs (Supple-
mentary Fig. 18a). The amino acids of this domain are not
conserved and are structurally ﬂexible (Supplementary Fig. 18b),
as conﬁrmed by the long GaMD simulations (Supplementary
Fig. 7). The ﬂexible HLH domain is close to the active site, which
indicates this domain may be involved in the recognition of the
acceptor protein substrates containing death domains. In fact,
GaMD simulations of the grafted SseK2:UDP-GlcNAc:FADD
complex show that the HLH domain interacts directly with
FADD C-terminal α-helix through side chain complementarity
(Supplementary Fig. 12). These data support the role of the HLH
domain in the recognition of the acceptor protein substrates
containing death domains.
STD NMR spectroscopy revealed that, in contrast to their
enzymatic activity proﬁle, both SseK1 and SseK2 interact with all
short peptides from FADD, TRADD, and GAPDH (Fig. 5, Sup-
plementary Fig. 5). Each of these peptides contains a conserved
WR-motif, which forms a key structural requirement for binding
to the enzymes, as revealed by STD NMR spectroscopy and
molecular modeling. Therefore it appears that recognition of
death domains may be due to complementarity with the active
site, whilst distinction between different death domain-containing
proteins is mediated through interactions far from the active site.
Overall our data provide compelling evidence of the molecular
basis for Arg glycosylation, the differences in substrate speciﬁcity
among orthologs, and will provide a framework for the design of
pan-NleB/SseK inhibitors targeting enteric pathogens.
Methods
Protein puriﬁcation. SseK1(21-336) gene was generated and ampliﬁed by PCR
from synthesized DNA and cloned into a modiﬁed pET28a (Novagen) in which the
thrombin cleavage site was replaced with a tobacco tech virus (TEV) protease
cleavage site. SseK2 (34-348) and NleB2 (1-316) gene were generated and ampliﬁed
by PCR from Salmonella typhimurium (strain SL1344), Escherichia coli O145:H28
(strain RM12581) respectively and cloned into the pVFT3S vector (Korean patent
10-0690230), which has 6xHis-thioredoxin (Trx) and TEV protease cleavage site
(Supplementary Table 2, Supplementary Table 3). PCR-based site-directed
Fig. 6 HEN motif plays a key role in NleB/SseK enzyme activity. a SseK1 mutants were generated and the cellular function in HEK293T cells was
investigated. A non-reducing gel (right panel) was used to conﬁrm the presence of the TRADD oligomer. Mutants in red represent mutations of residues
proposed to be catalytically important. Data represent at least three repetitions. b The NF-κB level in A549-NF-κB luc cells was measured to check the
enzymatic functions. Data represent the mean and standard deviation in triplicate. Multiple comparisons perform by one-way ANOVA followed by
Turkey’s Multiple Comparison Test (**P < 0.01, ***P < 0.001 compare to WT). c Enzyme kinetic assays of SseK1 and SseK2, respectively. d In vitro
glycosylation of FADD by NleB1, NleB2 (top panel) and SseK1 and SseK2 HEN mutants (bottom panel). e In vitro glycosylation of TRADD by NleB1, NleB2
(top panel) and SseK1 and SseK2 HEN mutants (bottom panel). f In vitro glycosylation of GAPDH by NleB1, NleB2 (top panel) and SseK1 and SseK2 HEN
mutants (bottom panel). g Glycosylation of TRADD after co-transfection with either NleB1 or SseK1 (WT and HEN mutants) in HEK293T cells. FLAG-
TRADD was immunoprecipitated and then immunoblotted using an anti-Arg-GlcNAc antibody. h Glycosylation of GAPDH after co-transfection with either
NleB1 or SseK1 (WT and HEN mutants) in HEK293T cells. FLAG-TRADD was immunoprecipitated and then immunoblotted using an anti-Arg-GlcNAc
antibody. i Colonization (log10 CFUs/g colon) of indicated C. rodentium strains (14 days post-gavage) in C57BL/6 J mice (n= 6). Asterisks indicate
signiﬁcantly different colonization magnitude as compared to WT; Kruskal-Wallis test. Uncropped blots are shown in Supplementary Figs. 21 and 22
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mutagenesis was employed to generate various point mutations. Complete amino
acid sequences are shown in Supplementary Table 4.
Each sub-cloned plasmid was transformed into E. coli BL21(DE3) (Novagen)
and grown in high salt Luria-Broth medium. When the O.D600 reached 0.6 ~ 0.8,
the temperature was decreased to 17 °C and the culture was induced with 0.3 mM
IPTG (isopropyl 1-thio-ß-D-galactopyranoside). After 16 h incubation, each
protein was puriﬁed using nickel-afﬁnity chromatography. Cell was lysed using
lysis buffer (20 mM Tris-NaCl pH 7.5, 300 mM NaCl, 30 mM imidazole, 10%
glycerol) and the proteins were eluted using an elution buffer of 300 mM imidazole
in lysis buffer. Thereafter, the TEV recognition site was cleaved using TEV
protease. After desalting to 20 mM Tris-HCl (pH7.5), 50 mM NaCl, each protein
was loaded into an anion-exchange chromatography column (Hitrap-Q, GE
healthcare) and then gel-ﬁltration chromatography (Superdex-200, GE healthcare)
was carried out in SEC buffer (25 mM HEPES-NaOH [pH7.5], 300 mM NaCl).
Selenomethionine substituted NleB2 was prepared using E. coli B834 (Novagen)
and cultured in M9 minimal media supplemented with glucose, amino acids, and
L-selenomethionine (Calbiochem). Expression condition and puriﬁcation method
were the same as for native NleB2.
NleB/SseK genes were also cloned into pET42a and then subjected to site-
directed mutagenesis. GAPDH and TRADD were cloned into pET28a. FADD was
cloned into pET15b. Proteins were puriﬁed after their overexpression in E. coli
BL21(DE3) using Ni-NTA agarose. NleB/SseK genes were sub-cloned into pCMV
tag 2a, pCMV Myc or (HA tag vector) for mammalian expression. TRADD gene
was cloned into pCMV tag 2a or pEGFP N1.
Crystallization and data collection. Puriﬁed SseK1 and SseK2 were concentrated
to 25 mg/mL and co-crystallized with 5 mM UDP and 5 mM MnCl2. Initial crys-
tallization screening was conducted by using Mosquito robot (TTP Labtech.) and
single, appropriate size of crystals appeared at 0.1 M Bis-Tris propane-HCl (pH
7.0), 1.0 M ammonium citrate tribasic [pH 7.0] and 0.1 M Bis-Tris [pH 6.5], 26%
(w/v) PEG3350, respectively. SseK2 apo crystals appeared 0.1 M HEPES-NaOH
[pH 7.5], 0.1 M sodium acetate, 24% (w/v) PEG4000 and for revealing UDP-
GlcNAc bound SseK2 structure, 5 mM MnCl2, 5 mM UDP-GlcNAc were added
into SseK2 apo crystal drop. 13 mg/mL of puriﬁed NleB2 formed crystals at 0.8 M
LiCl2, 0.1 M Tris-HCl [pH8.5], 8% (w/v) PEG3350. The Se-Met derivative of NleB2
crystallized under the same conditions. 20 % ethylene glycol was added as a cryo-
protectant to each crystal solution and ﬂash frozen in liquid nitrogen.
All of the crystal diffraction experiments were carried out at Photon factory
(KEK, Tsukuba, Japan). UDP or UDP-GlcNAc bound SseK2 and UDP bound
SseK1 were diffracted at BL-5A, BL-1A beamline, respectively. Native NleB2 and
Se-Met derivative NleB2 crystal was diffracted at BL-17A.
Structure determination and reﬁnement. Diffraction data sets were processed
and scaled with the programs imosﬁlm41 and Aimless from the CCP4 program
suite. The phasing information was solved by SAD method from Se-Met derivative
NleB2 crystal using AutoSol program and the other proteins were solved by
molecular replacement using NleB2 structure. MOLREP, REFMAC5, and COOT
were used for molecular replacement, structure reﬁnement, and further modeling,
respectively. All ﬁgures were prepared using PYMOL.
Peptide assignment and STD NMR. All experiments were performed at 288 K on
a Bruker Avance III 800MHz spectrometer equipped with a 5-mm TXI 800MHz
H-C/N-D-05 Z BTO probe. FADD110-118 and GAPDH195-203 (Genscript) samples
were prepared at 1 mM in 90% H2O/ 10% D2O and assigned using standard COSY
(cosydfesgpph), TOCSY (mlevphpr), and 1H-13C HSQC (hsqctgpsp) experiments.
Apo-enzyme samples were prepared with 1 mM peptide and 25 μM enzyme in
either 25 mM Tris-d11 (SseK1) or 10 mM PBS (SseK2); both at pH 7.4 in D2O.
Holoenzyme samples were prepared in the same way, with the addition of 25 μM
MnSO4 and 25 μM UDP. The residual water signal was used as a reference for
chemical shifts. STD NMR experiments were performed using a train of 50 ms
Gaussian pulses (0.4 mW, B1 ﬁeld strength 78 Hz) applied on the f2 channel at
either 0 ppm (on-resonance) or 40 ppm (off resonance). A spoil sequence (2 trim
pulses of 2.5 and 5 ms followed by a 40 % z-gradient applied for 3 ms at the
beginning of the experiment) was used to destroy unwanted x,y-magnetization
from previous scan and a spinlock (1.55W, 40 ms) was used to suppress protein
signals (stddiff.3). The saturation time (d20) was set to 2 s and the recycle delay
(d1) was set to 5 s.
Conﬁguration of GlcNAc in the glycosylated peptide. Samples for peptide
glycosylation were prepared by adding either 7.5 mM FADD110-118 or 7.7 mM
GAPDH187-203 to 50 mM UDP-GlcNAc, 40 μM SseK1, and 2 mMMnCl2 in 25 mM
Tris pH 7.5, allowing the reaction to proceed for 24 h at 37 °C. The resulting
glycopeptide was puriﬁed from the enzyme by using an Amicon® Ultra 10 K device.
NMR experiments for the GAPDH187-203 sample were then performed at 298 K,
and consisted of a decoupled 1H-13C HSQC (hsqcetgpsi), and TOCSY with water
suppression (mlevgpph19) at 800MHz, and a Perfect-CLIP-HSQC42 at 500MHz
(with a digital resolution of 1.6 Hz, to determine the 1JC,H coupling of the anomeric
carbon of the transferred GlcNAc residue). The HSQC recycle delay was 1.5 s. For
the TOCSY, the recycle delay was 2 s and the mixing time was 80 ms. For the
FADD110-118 sample, a decoupled 1H-13C HSQC was recorded as above, in a
Bruker Avance I 500MHz spectrometer, equipped with a triple resonance indirect
detect TXI probe with Z-gradients.
Molecular docking calculations for guanidine-SseK2. UDP-bound
SseK2 structure and guanidine was loaded to Discovery Studio 4.0 and the possible
binding site was set (Radius= 10 Å, XYZ= 21.197,−9.134, 12.013). The algorithm
was taken from the CHARMm protocol and the best score was selected
(-CDOCKER ENERGY= 18.192, -CDOCKER INTERACTION ENERGY=
18.097)
Molecular docking calculations for FADD-SseK2. Crystal structures of SseK1,
SseK2, and FADD (PDB 3EZQ) were imported into Schrödinger Maestro43 and
prepared with the Protein Preparation Wizard44. All buffer atoms and non-
bridging waters were removed. Protons were then added to the model, using
PROPKA to predict the protonation state of polar sidechains at pH 745. The
hydrogen-bonding network was automatically optimized by sampling asparagine,
glutamine, and histidine rotamers. The model was then minimized using OPLS346
force ﬁeld and a heavy atom convergence threshold of 0.3 Å.
A model of the FADD110-118 peptide was created by truncation of the FADD
crystal structure. Conformers were generated in MacroModel using torsional
sampling with the OPLS3 forceﬁeld, constraining all backbone atoms. Redundant
conformers were eliminated using an RMSD cutoff of 0.5 Å. Any conformer with
an energy 5 kcal mol-1 greater than the lowest energy structure was also eliminated.
Resulting conformers were then minimized using the conjugate gradient method,
converging on a threshold of 0.05 kcal mol-1. Docking of FADD110-118 to SseK2 was
then performed using Glide47,48. A cubic grid, suitable for peptide docking, was
generated. It was centered on UDP-GlcNAc, with an outer box length of 45 Å and
an inner box length of 40 Å. To account for ﬂexibility, van der Waals potentials of
all receptor and ligand atoms were scaled by 0.5. All ligand conformers were
docked to the receptor using rigid sampling with the SP algorithm. The resulting
complexes were then clustered by heavy atom RMSD to eliminate redundant poses,
keeping the structure closest to the cluster centroid from each cluster. All
sidechains within 5 Å of the ligand were then optimized before minimizing using
Prime49. A second round of docking was performed, as described above, on the
new receptor structures. The resulting complexes were clustered by heavy atom
RMSD, and the lowest energy representative structure was chosen for analysis.
A model of SseK2 in complex with full length FADD was generated by aligning
the backbone atoms of residues 110-118 in the full-length structure to the backbone
of the docked FADD110-118 structure. Prime optimization and minimization within
5 Å of the contact surface was used to eliminate an atomic overlap.
Molecular dynamics. UDP charges for use with UDP-GlcNAc were derived using
the RESP ﬁtting method implemented on the RED server50. The UDP fragment
was generated by replacing the GlcNAc with a methyl group. In accordance with
GLYCAM51, the HF/6-31G* level of theory was used with a weight factor of 0.01
and all aliphatic protons were constrained to a charge of 0. The total charge of the
UDP fragment was set to −2. The charge of the methyl group was set to 0.194
before removing to give a ﬁnal fragment with net charge −2.194, in keeping with
the modularity of GLYCAM.
Molecular dynamics simulations of SseK1, SseK2, and the SseK2:FADD
complex were performed using the Amber PMEMD software52. Protein atoms
were parameterized using the Amber ff11SB forceﬁeld and the Mn2+ ion was
modeled using 12-6-4 LJ-type parameters (Amber ions234lm_1264_tip3p). UDP-
GlcNAc was parameterized with GLYCAM 06j and GAFF. Each system was
solvated in a truncated octahedral box of TIP3P water, with at least 10 Å between
the solute and the edge of the box, before neutralizing with Na+ ions. The system
was minimized using the conjugate gradient algorithm, converging on a threshold
of 10−4 kcal mol−1 A−1, ﬁrst with 20 kcal mol−1 A−2 restraints on solute atoms,
before repeating with no restraints. The system was slowly heated to 310 K over
500 ps (NVT), before equilibrating the pressure to 1 atm (NPT) over a further 500
ps. In both cases with 20 kcal mol−1 A−2 restraints were used on solute atoms.
These restraints were then slowly released over 800 ps before performing Gaussian
accelerated molecular dynamics (GaMD) simulations (800 ns SseK1/SseK2, 500 ns
SseK2:FADD complex), as implemented in AMBER, using a boost potential on
both the dihedral and total potential energies. Here, the simulation was split into 4
distinct stages. First, conventional dynamics were run for 2 ns to automatically
calculate an initial boost potential. The calculated boost potential was then applied
and ﬁxed for 400 ps before allowing it to adapt for a further 5.6 ns. The resulting
boost potential was then ﬁxed before performing production dynamics for 800 ns
(SseK1/SseK2) or 500 ns (SseK2:FADD complex), saving coordinates every 100 ps.
In all cases, the SHAKE algorithm was used to restrain all bonds involving
hydrogen, allowing for a time step of 2 fs. A Langevin thermostat was used with a
collision frequency of 5 ps−1 and the barostat used an isotropic Berendsen
algorithm with a relaxation time of 1 ps. In all cases, periodic boundary conditions
were used, using the particle mesh Ewald to calculate electrostatics.
Cell culture. Human embryonic kidney (HEK) 293T (ATCC, ATCC® CRL-3216™)
and A549 NF-κB luciferase cells (Panomics, RC0002) were cultured in DMEM
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supplemented with 10% fetal bovine serum (FBS, Cellgro), 100 U/ml penicillin,
100 μg/ml streptomycin, and 2 mM L-glutamine at 37 °C in 5% CO2.
Western blot analysis and immunoprecipitation. HEK293T cells were trans-
fected with various combinations of plasmids using Lipofectamine 2000 (Invitro-
gen) as speciﬁed by the manufacturer. Cells were washed with phosphate-buffered
saline (PBS) and lysed in 1 × RIPA buffer (GenDEPOT, Barker, TX, USA) con-
taining 150 mM NaCl, 1% Triton X-100, 1% deoxycholic acid sodium salt, 0.1 %
sodium dodecyl sulfate (SDS), 50 mM Tris-HCl (pH 7.5), 2 mM EDTA, and a
protease inhibitor cocktail. Whole cell lysates (WCLs) were centrifuged at 13,000
rpm for 10 min at 4 °C. To detect TRADD oligomerization, WCL were separated
using a non-reducing sample buffer. About 30 μg of proteins were separated by
SDS-PAGE and transferred to nitrocellulose membranes (GE Healthcare, Little
Chalfont, UK). Non-speciﬁc binding was blocked, and anti-GFP (1:3000, Santa
Cruz, CA, USA, SC-8334, SC-9996), anti-actin (1:5000, Cell Signaling Technology,
Danvers, MA, USA, #4967), and anti-PARP (1:1000, Cell Signaling Technology,
Danvers, MA, USA, #9542) anti-c-Myc (1:3000, Invitrogen, Camarillo, CA, USA,
13-2500) antibodies were used as primary antibodies. After washing, membranes
were probed with the HRP-conjugated secondary antibody for 1 h. Enhanced
chemiluminescent substrate (GenDEPOT, Barker, TX, USA) was used for
visualization.
Immunoprecipitation was performed with 15 μl of dynabeads protein G
(Invitrogen, Camarillo, CA, USA). The beads were washed and incubated with 1 μg
of the antibody for 1 h at RT. The beads were incubated with 300 μg WCL
overnight at 4 °C after washing. Samples were separated using SDS-PAGE for
immunoblotting. UDP-GlcNAc (1 mM) and MnCl2 (5 mM) were added to
recombinant SseK1 and incubated at 37 °C for 1 h. The same amount of wild type
and auto-glycosylated SseK2 were loaded into 15% SDS-PAGE gel and anti-
GlcNAc antibody (1:5000, CTD110.6, Santa Cruz, CA, USA, #sc-59623 used to
detect GlcNAcylated arginine).
NF-κB luciferase assay. A549 cells (Panomics, RC0002) stably expressing NF-κB
were transfected with a mixture of pNL1.1.TK[Nluc/TK], GFP-TRADD and var-
ious Myc-SseK1 plasmids. pNL1.1.TK[Nluc/TK] was used for transfection control.
After 24 h, the cells were treated with 20 ng/ml TNF-α for 6 h. Luciferase assay was
performed using Dual-Luciferase Reporter Assay system (Promega, E1910). Brieﬂy,
cells were lysed with Luciferase Cell Culture Lysis Reagent and Luciferase Assay
Reagent II was added to measure the luciferase activity. Stop & Glo Reagent was
added into tube to quench ﬁreﬂy luciferase activity, and nanoLuc luciferase activity
was measured using a luminometer.
Glycosyltransferase kinetics assay. Recombinant SseK1, SseK2 and point mutant
proteins were prepared as described and GT kinetics were measured using UDP-
GloTM Glycosyltransferase Assay kit (Promega, #V6961) by manufacturer’s instruc-
tion. Enzyme reaction buffer (ERB) was prepared as 25mM Tris-HCl [pH 7.5], 50
mM NaCl, 4mM MnCl2, 1mM DTT and reaction was eliminated by using the
nucleotide detection buffer. For preparing the acceptor-substrate, L-arginine (Duchefa
BIOCHEMIE, > 98.5% purity) was dissolved in ERB. Synthetic peptides of GAPDH
(Genscript, > 90% purify) was purchased and dissolved in ERB. White 96-well plates
(ThermoScientiﬁc) were used for luminescence assay and the plate was read by using
luminometer (VictorX5, PerkinElmer). Kinetics parameters were calculated using
GraphPad Prism5 ver.5.03 software. The points represent an average of two samples
and error bars represent mean ± S.D. The ﬁnal speciﬁc activity of the transfer reaction
was corrected considering the hydrolysis reaction, which was performed using SseK1/
SseK2, UDP-GlcNAc, and MnCl2.
Mouse infections. All animal experiments were performed according to Institu-
tional Animal Care and Use Committee-approved protocols (Animal Welfare
Assurance #3647) and conducted as previously described7. Female BALB/c mice
were obtained from the Jackson Laboratory, housed in microisolator cages, and
provided with food and water ad libitum. C. rodentium ΔnleB was electroporated
with pFLAG-CTC plasmids expressing EHEC nleB1 or nleB2 genes. Mice were
challenged with 1*108 CFUs of each strain and observed twice daily for 14 days.
Colon samples were dissected after euthanasia, homogenized, serially diluted in
PBS, and then plated on MacConkey agar to enumerate bacteria.
pH-dependent GT activity test. Glycosylation reactions were performed as
described previously18. Brieﬂy 200 nM of enzyme was mixed with 1 µM substrate in
the presence of 50 mM Tris-HCl pH 7.4, 1 mM UDP-GlcNAc, 10 mM MnCl2, and
1 mM DTT for 2 h at room temperature. Samples were subjected to Western blot
analysis using an anti-Arg-GlcNAc antibody (Abcam). The pH-dependence of
glycosylation was assessed under similar conditions except that the Tris-HCl was
replaced with McIlvaine buffers.
Isothermal titration calorimetry. ITC experiments were conducted in a MicroCal
VP-ITC (MicroCal) device. After size exclusion chromatography (SEC) in Tris-
HCl [pH 7.5], 150 mM NaCl, and 1 mM MnCl2, sample fractions corresponding to
the single UV280 peak were collected and concentrated to 0.2 mM by using 10 kDa
cut-off Amicon tubes. Ligands (4 mM) were dissolved in the same SEC buffer and
were titrated to variant SseK proteins at 25 °C. Binding stoichiometry, enthalpy
variation, entropy variation, dissociation constant and Chi-square values were
calculated using MicroCal Origin software.
Data availability
Coordinates and structure factors have been deposited in the Protein Data Bank under
the accession codes 5H5Y (NleB2 X-ray structure), 5H60 (UDP bound SseK1 X-ray
structure), 5H61 (SseK2 X-ray structure), 5H62 (UDP-bound SseK2 X-ray structure) and
5H63 (UDP-GlcNAc bound SseK2 X-ray structure). Other data are available from the
corresponding authors upon reasonable request.
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